doi:10.12300/j.issn.1674-5817.2025.213

Abstract

CLC Number:

Q95-33

References 16

[1]	孙强. 无替代,何谈取消[J]. 实验动物与比较医学, 2025, 45(3): 376-378. DOI: 10.12300/j.issn.1674-5817.2025.064 .
[2]	孙强. 非动物实验替代知多少[J]. 实验动物与比较医学, 2025, 45(4): 508-513. DOI: 10.12300/j.issn.1674-5817.2025.117 .
[3]	孙强. 中国实验猴产业的历史、现状、挑战与机遇[J]. 实验动物与比较医学, 2024, 44(4): 343-356. DOI: 10.12300/j.issn.1674-5817.2024.112 .
[4]	SCHÜRCH C M. Therapeutic antibodies for myeloid neoplasms-current developments and future directions[J]. Front Oncol, 2018, 18(8): 152. DOI: 10.3389/fonc.2018.00152 .
[5]	ADASHI E Y, O'MAHONY D P, COHEN I G. The FDA modernization act 2.0: drug testing in animals is rendered optional[J]. Am J Med, 2023, 136(9): 853-854. DOI: 10.1016/j.amjmed.2023.03.033 .
[6]	FDA. FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs[EB/OL]. (2025-04-10)[2025-09-15]. .
[7]	EFFER B, PEREZ I, ULLOA D, et al. Therapeutic targets of monoclonal antibodies used in the treatment of cancer: current and emerging[J]. Biomedicines, 2023, 11(7): 2086. DOI: 10.3390/biomedicines11072086 .
[8]	LEUNG C, JESSEN B, RATTEL B, et al. Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs - an IQ DruSafe industry survey[J]. Regul Toxicol Pharmacol, 2025, 162: 105902. DOI: 10.1016/j.yrtph. 2025.105902 .
[9]	CHIEN H T, PRIOR H, ANDREWS L, et al. Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach[J]. Regul Toxicol Pharmacol, 2023, 138: 105329. DOI: 10.1016/j.yrtph.2022.105329 .
[10]	RALSTON S L, LI L, LEE D, et al. Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads[J]. Regul Toxicol Pharmacol, 2025, 162: 105887. DOI: 10.1016/j.yrtph.2025.105887 .
[11]	KHONGORZUL P, LING C J, KHAN F U, et al. Antibody-drug conjugates: a comprehensive review[J]. Mol Cancer Res, 2020, 18(1): 3-19. DOI: 10.1158/1541-7786.MCR-19-0582 .
[12]	RICCARDI F, BO M DAL, MACOR P, et al. A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy[J]. Front Pharmacol, 2023, 14: 1274088. DOI: 10.3389/fphar.2023.1274088 .
[13]	DRAGO J Z, MODI S, CHANDARLAPATY S. Unlocking the potential of antibody-drug conjugates for cancer therapy[J]. Nat Rev Clin Oncol, 2021, 18(6): 327-344. DOI: 10.1038/s41571-021-00470-8 .
[14]	CONNORS J M, JURCZAK W, STRAUS D J, et al. Brentuximab vedotin with chemotherapy for stage Ⅲ or Ⅳ Hodgkin's lymphoma[J]. N Engl J Med, 2018, 378(4): 331-344. DOI: 10.1056/nejmoa1708984 .
[15]	COLOMBO R, RICH J R. The therapeutic window of antibody drug conjugates: a dogma in need of revision[J]. Cancer Cell, 2022, 40(11): 1255-1263. DOI: 10.1016/j.ccell.2022.09.016 .
[16]	NEFF-LAFORD H D, CARRATT S A, CAROSINO C, et al. The vedotin antibody-drug conjugate payload drives platform-based nonclinical safety and pharmacokinetic profiles[J]. Mol Cancer Ther, 2024, 23(10): 1483-1493. DOI: 10.1158/1535-7163.mct-24-0087 .

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 16

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	CHEN Ziyi, SUN Hongyan, KANG Pinfang, WU Wenjuan. Research Advances in Construction Methods and Novel Technologies for Animal Models of Pulmonary Hypertension [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 81-93.
[2]	LIAO Wangyue, LEI Shuang, LI Xuan, GUO Min, ZHOU Ruoran. Literature Analysis and Validity Assessment for Animal Models of Attention Deficit and Hyperactive Disorder [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 66-80.
[3]	XU Bo, CHEN Tairen, FANG Qian, WU Ji. Research on Spatiotemporal Gene Expression Profiles and Repair Mechanisms of Spinal Cord Compression and Hemisection Spinal Cord Injury Mouse Models [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 32-45.
[4]	XIAO Fangping, XIONG Lijuan, JIA Bo, LIU Huan, LUO Yongbing, WAN Xiaorong. Analysis of Microbiological and Parasitic Testing Results for Laboratory Animals in Jiangxi Province, 2020-2024 [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 119-126.
[5]	LIU Chang, XIANG Xuesong, HE Huihuang, CHEN Xiaoqing, QIU Wenhong. Establishment and Evaluation of an Oxidative Stress Model of Atopic Dermatitis Induced by 2,4-dinitrofluorobenzene [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 46-54.
[6]	ZHENG Qingyong, ZHOU Yongjia, LI Tengfei, XU Jianguo, TIAN Chen, LIU Hui, TIAN Min, ZHOU Ziyu, XU Caihua, CUI Yating, WANG Junfei, TIAN Jinhui. Standardization Challenges in Outcome Evaluation Systems of Animal Experiments and Considerations for Core Outcome Set Construction Strategies [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 138-148.
[7]	LI Xiaoqin, YU Wenlan, DUAN Yizhu, LIU Zhonghua, WU Guodong, SHI Wenqi, FU Hongkun. Construction of Laboratory Animal Science and Technology Ethics Governance System in China and Its Preliminary Practice in Guangdong Province [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 127-137.
[8]	YANG Lin, JIN Meng, WU Hanqing, LI Shun, ZHOU Xiaohui. Establishment and Preliminary Analysis of an AG6 Mouse Encephalopathy Model Induced by Vaccinia Virus Tiantan Strain Infection [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 3-10.
[9]	HE Jiaqi, ZHOU Yuanyuan, NIE Yongqiang, WANG Zhaoxia, XU Wangjie. Establishment and Multidimensional Pathological Evaluations of a Cigarette Smoke Exposure-Induced Chronic Obstructive Pulmonary Disease Mouse Model [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 11-19.
[10]	XU Yingtao, WANG Mengmeng, LIN Ping, CHI Haitao, WANG Yi, BAI Ying. Exosomes Treat Ischemic Stroke by Regulation of Ferroptosis Through the NRF2/SLC7A11/GPX4 Pathway in Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 20-31.
[11]	WANG Hanyue, CHEN Jiawei, GAO Xiangbin, LUO Wei, LIU Suning. Research Overview on Corpora Cardiaca Function of Drosophila melanogaster [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 705-718.
[12]	SHENG Lihong. Harpegnathos saltator : A Model Insect for Decoding Plasticity of Social Behavior and Aging [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 762-772.
[13]	YUN Jiaqi, MA Qin, WANG Guandong, SUN Peilu, WANG Yiguan, WANG Sibao. Research Advances and Challenges of Gene Drive Technology in Mosquito-Borne Disease Control [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 773-783.
[14]	SONG Mengjiao, SHEN Yidong. Approaches and Application Examples for Studying Mitochondrial Morphology and Function in Caenorhabditis elegans [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 726-737.
[15]	ZHOU Guanyu, ZHU Shiming, LIU Fangfang. Research Advances on Periplaneta americana as an Experimental Animal Model [J]. Laboratory Animal and Comparative Medicine, 2025, 45(6): 794-802.